Olanzapine Tablet, Orally Disintegrating
Product Images NDC 64380-175
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64380-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 02)
Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 03)
Principal Display Panel 15 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 04)
Principal Display Panel 20 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.